208 related articles for article (PubMed ID: 29907543)
1. Acute Liver Failure Associated With Pomalidomide Therapy for Multiple Myeloma.
Reed-Guy L; Hoteit MA; Garfall AL
Clin Lymphoma Myeloma Leuk; 2018 Aug; 18(8):e337-e338. PubMed ID: 29907543
[No Abstract] [Full Text] [Related]
2. Thalidomide-induced severe hepatotoxicity.
Dabak V; Kuriakose P
Cancer Chemother Pharmacol; 2009 Mar; 63(4):583-5. PubMed ID: 19083237
[No Abstract] [Full Text] [Related]
3. A case of acute liver failure due to carfilzomib in multiple myeloma.
Kathi PR; Tama M; Kundumadam S; Naylor P; Mutchnick M
J Clin Pharm Ther; 2018 Dec; 43(6):918-920. PubMed ID: 29969517
[TBL] [Abstract][Full Text] [Related]
4. [Fulminant hepatitis].
Yasuda H; Yoshiba S
Nihon Rinsho; 2007 Oct; 65 Suppl 8():545-8. PubMed ID: 18074599
[No Abstract] [Full Text] [Related]
5. Pomalidomide in heavily pretreated refractory multiple myeloma: a case report.
Palmas A; Piras G; Uras A; Asproni R; Murineddu M; Monne M; Stradoni R; Latte G
Future Oncol; 2017 Feb; 13(5s):7-9. PubMed ID: 28116939
[TBL] [Abstract][Full Text] [Related]
6. Pomalidomide therapy for multiple myeloma and myelofibrosis: an update.
Lacy MQ; Tefferi A
Leuk Lymphoma; 2011 Apr; 52(4):560-6. PubMed ID: 21338284
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary toxicity associated with pomalidomide.
Gajic S; Callahan EC; Brown JK; Elicker B; Ley B; Blanc PD
Int J Tuberc Lung Dis; 2018 Nov; 22(11):1383-1386. PubMed ID: 30355421
[TBL] [Abstract][Full Text] [Related]
8. [Acute liver failure in nefazodone therapy? A case report].
Ehrentraut S; Rothenhäusler HB; Gerbes AL; Rau HG; Thiel M; Schirren CA; Kapfhammer HP
Nervenarzt; 2002 Jul; 73(7):686-9. PubMed ID: 12212533
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug reaction: pomalidomide-induced liver injury.
Veluswamy RR; Ward SC; Yum K; Abramovitz RB; Isola LM; Jagannath S; Parekh S
Lancet; 2014 Jun; 383(9935):2125-6. PubMed ID: 24953475
[No Abstract] [Full Text] [Related]
10. Pomalidomide. A last-line treatment option for multiple myeloma.
Prescrire Int; 2014 Nov; 23(154):257-9. PubMed ID: 25954788
[TBL] [Abstract][Full Text] [Related]
11. A case of acute kidney injury from crystal nephropathy secondary to pomalidomide and levofloxacin use.
Baird P; Leung S; Hoang H; Babalola O; Devoe CE; Wanchoo R; Jhaveri KD
J Oncol Pharm Pract; 2016 Apr; 22(2):357-60. PubMed ID: 25591868
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience.
Sriskandarajah P; Pawlyn C; Mohammed K; Dearden CE; Davies FE; Morgan GJ; Boyd KD; Kaiser MF
Leuk Lymphoma; 2017 Feb; 58(2):494-497. PubMed ID: 27439571
[No Abstract] [Full Text] [Related]
13. Benzbromarone: a double-edged sword that cuts the liver?
Haring B; Kudlich T; Rauthe S; Melcher R; Geier A
Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):119-21. PubMed ID: 23196726
[No Abstract] [Full Text] [Related]
14. Acute lung toxicity related to pomalidomide.
Geyer HL; Viggiano RW; Lacy MQ; Witzig TE; Leslie KO; Mikhael JR; Stewart K
Chest; 2011 Aug; 140(2):529-533. PubMed ID: 21813533
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, safety, and cost of pomalidomide in relapsed and refractory multiple myeloma.
Gueneau P; Chretien ML; Cransac-Miet A; Aho LS; Lafon I; Favennec C; Guy J; Caillot D; Boulin M
Eur J Haematol; 2018 May; 100(5):518-525. PubMed ID: 29393533
[TBL] [Abstract][Full Text] [Related]
16. Desensitization to lenalidomide in a patient with relapsed multiple myeloma.
Seki JT; Banglawala S; Lentz EM; Reece DE
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):162-5. PubMed ID: 23103087
[No Abstract] [Full Text] [Related]
17. Thalidomide-induced acute cholestatic hepatitis: case report and review of the literature.
Vilas-Boas F; Gonçalves R; Sobrinho Simões M; Lopes J; Macedo G
Gastroenterol Hepatol; 2012 Oct; 35(8):560-6. PubMed ID: 22789729
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide-induced severe hepatotoxicity.
Hanje AJ; Shamp JL; Thomas FB; Meis GM
Pharmacotherapy; 2006 Jul; 26(7):1018-22. PubMed ID: 16803426
[TBL] [Abstract][Full Text] [Related]
19. [A case of the successful treatment of drug-induced toxic hepatitis in a child with tuberculous meningoencephalitis].
Kalugin AV; Kolesnikova IV; Zhuravleva LIu; Churiumova OG; Maĭorov VM
Anesteziol Reanimatol; 1998; (1):68-9. PubMed ID: 9553268
[No Abstract] [Full Text] [Related]
20. Alternate day pomalidomide retains anti-myeloma effect with reduced adverse events and evidence of in vivo immunomodulation.
Streetly MJ; Gyertson K; Daniel Y; Zeldis JB; Kazmi M; Schey SA
Br J Haematol; 2008 Apr; 141(1):41-51. PubMed ID: 18324965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
